InflaRx N.V. - Ordinary Shares, nominal value 0.12 EUR per share (IFRX)

CUSIP: N44821101

Q1 2025 13F Holders as of 31 Mar 2025

Holder snapshot 7 signals
Share change
+4,519,681
Put/Call ratio
6.6%
SEC-reported price per share
$1.02
Number of holders
31
Value change
+$4,372,526
Number of buys
17
Open additional details 1 more signal available
Number of sells
15
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
146,568,627

Security key

N44821101

Report period

Q1 2025

Institutions

31

Top holders

10

Ownership snapshot

Top reported holders of IFRX - InflaRx N.V. - Ordinary Shares, nominal value 0.12 EUR per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
MONTANOVA CAPITAL, LLC
Disclosed value leader
MONTANOVA CAPITAL, LLC
Comparable rows
0/15
Latest evidence
31 Dec 2024
13F Highest disclosed value: $14,162,758 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

MONTANOVA CAPITAL, LLC has the largest disclosed position value at $14.16M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens MONTANOVA CAPITAL, LLC's linked filing trail.
Disclosed position value Top 5
MONTANOVA CAPITAL, LLC $14.16M
683 Capital Management, LLC $5.11M
MORGAN STANLEY $5.03M
NORTHERN TRUST CORP $1.65M
RAYMOND JAMES FINANCIAL INC $1.58M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
MONTANOVA CAPITAL, LLC
13F
Company
13F
—
denominator unverified
$14,162,758
5,733,910 shares
— 31 Dec 2024
683 Capital Management, LLC
13F
Company
13F
—
denominator unverified
$5,112,900
2,070,000 shares
— 31 Dec 2024
MORGAN STANLEY
13F
Company
13F
—
denominator unverified
$5,034,269
2,038,166 shares
— 31 Dec 2024
NORTHERN TRUST CORP
13F
Company
13F
—
denominator unverified
$1,647,107
666,845 shares
— 31 Dec 2024
RAYMOND JAMES FINANCIAL INC
13F
Company
13F
—
denominator unverified
$1,576,087
638,092 shares
— 31 Dec 2024
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC)
13F
Company
13F
—
denominator unverified
$1,545,205
625,589 shares
— 31 Dec 2024
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
31
Shares
17,520,291
Rows available
31
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2025 vs Q1 2025 Across Filers

Q1 2025 holders
31
Q1 2025 holders
31
Holder diff
0
Investor Q1 2025 Shares Q1 2025 Shares Share Diff Share Chg % Q1 2025 value Q1 2025 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .